UPDATE: Morgan Stanley Reiterates On Solazyme As Moema COD Significantly Derisks Story
May 30, 2014 at 10:31 AM EDT
In a report published Friday, Morgan Stanley analyst Timothy Radcliff reiterated an Overweight rating on Solazyme (NASDAQ: SZYM), but ...